Modulation of the Brain Fog Scale by Eicosapentaenoic Acid Monoglycerides (MAG-EPA).
Clinical trial NCT06695910 · RECRUITING
Trial details
- NCT number
- NCT06695910
- Sponsor
- Samuel Fortin
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-06
- Primary completion
- 2027-05-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.